Labcorp to Introduce Combined Oncology Offering at 2021 ASCO® Annual Meeting
Presentation Features Labcorp’s Combined Oncology Diagnostic and Drug Development Platform for Clinicians and Biopharmaceutical CompaniesBURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the introduction of its combined Labcorp oncology platform at the vir...
United States Prasanth Reddy Robert Phillips Drug Development Platform For Clinicians Biopharmaceutical Companies Labcorp Drug Development
Source: pharmiweb.com